Chemours
455 hedge funds and large institutions have $3.23B invested in Chemours in 2023 Q3 according to their latest regulatory filings, with 50 funds opening new positions, 109 increasing their positions, 166 reducing their positions, and 66 closing their positions.
0.87% more ownership
Funds ownership: 76.95% → 77.83% (+0.87%)
4% less funds holding
Funds holding: 476 → 455 (-21)
17% less call options, than puts
Call options by funds: $57.3M | Put options by funds: $69.1M
24% less capital invested
Capital invested by funds: $4.23B → $3.23B (-$996M)
24% less first-time investments, than exits
New positions opened: 50 | Existing positions closed: 66
33% less funds holding in top 10
Funds holding in top 10: 6 → 4 (-2)
34% less repeat investments, than reductions
Existing positions increased: 109 | Existing positions reduced: 166
Top Buyers
| 1 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$59.1M |
| 2 |
Millennium Management
New York
|
+$34.4M |
| 3 |
Marshall Wace
London,
United Kingdom
|
+$31.7M |
| 4 |
Bank of New York Mellon
New York
|
+$21M |
| 5 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
+$16.7M |
Top Sellers
CC Hedge Fund Activity: Q3 2023 in Review
455 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Chemours (CC) for Q3 2023, worth a combined $3.23B — down 24% from $4.23B a quarter earlier.
Sellers outnumbered buyers: 66 funds closed out of CC and 50 opened new positions — a net loss of 16 holders — while 166 trimmed existing stakes and 109 added.
The largest buyer was Deutsche Bank, adding an estimated $59.1M. The largest seller was Fidelity Investments, cutting an estimated $50.8M.
- 455 institutional investors held Chemours (CC) as of Q3 2023, down from 476 in Q2 2023.
- Funds reported $3.23B of Chemours stock for Q3 2023, down 24% quarter-over-quarter.
- 50 funds opened new Chemours positions in Q3 2023 and 66 closed out, a net change of -16 holders.
- The largest Chemours buyer in Q3 2023 was Deutsche Bank, an estimated $59.1M added.
- The largest Chemours seller in Q3 2023 was Fidelity Investments, an estimated $50.8M sold.
Based on aggregated 13F filings for Q3 2023.